Granulomatous disease, chronic, X-linked: genes and variants
Explore variant evidence for Granulomatous disease, chronic, X-linked across 1 analyzed protein (CYBB). Linked ClinVar records include 39 pathogenic or likely pathogenic variants, 87 variants of uncertain significance and 12 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Source labels are pooled across this disease family.
Data updated 2026-11-05. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Granulomatous disease, chronic, X-linked
CYBB: NADPH oxidase 2
It generates the catalytic electron flow that allows phagocytes to produce microbicidal reactive oxygen species during the respiratory burst. Loss-of-function variants cause X-linked chronic granulomatous disease with severe susceptibility to bacterial and fungal infection.
39 ClinVar pathogenic / likely pathogenic and 99 uncertain variants in CYBB have source records linked to Granulomatous disease, chronic, X-linked. Association strength is not clinical gene validity.
ClinVar pathogenic and likely pathogenic variants linked to Granulomatous disease, chronic, X-linked
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| CYBB P415H | 415 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| CYBB D500Y | 500 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| CYBB P339H | 339 | FAD-binding FR-type | Pathogenic / likely pathogenic (★★) |
| CYBB A57E | 57 | Ferric oxidoreductase | Pathogenic / likely pathogenic (★★) |
| CYBB C537R | 537 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| CYBB M1V | 1 | Pathogenic / likely pathogenic (★★) | |
| CYBB R130P | 130 | Ferric oxidoreductase | Pathogenic / likely pathogenic (★★) |
| CYBB S142P | 142 | Ferric oxidoreductase | Pathogenic / likely pathogenic (★★) |
| CYBB P415R | 415 | Cytoplasmic | Pathogenic / likely pathogenic (★) |
| CYBB H338Q | 338 | FAD-binding FR-type | Pathogenic / likely pathogenic (★) |
| CYBB H338Y | 338 | FAD-binding FR-type | Pathogenic / likely pathogenic (★) |
| CYBB P415L | 415 | Cytoplasmic | Pathogenic / likely pathogenic (★) |
| CYBB D500E | 500 | Cytoplasmic | Pathogenic / likely pathogenic (★) |
| CYBB D500G | 500 | Cytoplasmic | Pathogenic / likely pathogenic (★) |
| CYBB M1I | 1 | Pathogenic / likely pathogenic (★) | |
| CYBB C64R | 64 | Ferric oxidoreductase | Pathogenic / likely pathogenic (★) |
| CYBB H101Y | 101 | Ferric oxidoreductase | Pathogenic / likely pathogenic (★) |
| CYBB H101R | 101 | Ferric oxidoreductase | Pathogenic / likely pathogenic (★) |
| CYBB G408R | 408 | Cytoplasmic | Pathogenic / likely pathogenic (★) |
| CYBB G408A | 408 | Cytoplasmic | Pathogenic / likely pathogenic (★) |
| CYBB G412R | 412 | Cytoplasmic | Pathogenic / likely pathogenic (★) |
| CYBB C537F | 537 | Cytoplasmic | Pathogenic / likely pathogenic (★) |
| CYBB G20R | 20 | Transmembrane | Pathogenic / likely pathogenic (★) |
| CYBB R54G | 54 | Ferric oxidoreductase | Pathogenic / likely pathogenic (★) |
| CYBB G179R | 179 | Ferric oxidoreductase | Pathogenic / likely pathogenic (★) |
| CYBB H222Q | 222 | Ferric oxidoreductase | Pathogenic / likely pathogenic (★) |
| CYBB G223L | 223 | Ferric oxidoreductase | Pathogenic / likely pathogenic (★) |
| CYBB C257R | 257 | Ferric oxidoreductase | Pathogenic / likely pathogenic (★) |
| CYBB F262C | 262 | Ferric oxidoreductase | Pathogenic / likely pathogenic (★) |
| CYBB W361R | 361 | FAD-binding FR-type | Pathogenic / likely pathogenic (★) |
| CYBB T362I | 362 | FAD-binding FR-type | Pathogenic / likely pathogenic (★) |
| CYBB E462A | 462 | Cytoplasmic | Pathogenic / likely pathogenic (★) |
| CYBB W516R | 516 | Cytoplasmic | Pathogenic / likely pathogenic (★) |
| CYBB E568K | 568 | Cytoplasmic | Pathogenic / likely pathogenic (★) |
| CYBB A156T | 156 | Ferric oxidoreductase | Pathogenic / likely pathogenic (★) |
| CYBB C244S | 244 | Ferric oxidoreductase | Pathogenic / likely pathogenic |
| CYBB H303N | 303 | FAD-binding FR-type | Pathogenic / likely pathogenic |
| CYBB P304R | 304 | FAD-binding FR-type | Pathogenic / likely pathogenic |
| CYBB G389A | 389 | FAD-binding FR-type | Pathogenic / likely pathogenic |
Uncertain variants prioritized for review in Granulomatous disease, chronic, X-linked
| Variant | Position | Protein part | Clinical label | Evidence |
|---|---|---|---|---|
| CYBB A57S | 57 | Ferric oxidoreductase | Conflicting reports (★) | +7: 2 other pathogenic changes within 3 positions; A57E at the same position is pathogenic; seen in 1.8e-06 of gnomAD DNA copies; REVEL 0.883 |
| CYBB T362K | 362 | FAD-binding FR-type | Uncertain (★) | +6: 2 other pathogenic changes within 3 positions; T362I at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.99 |
Which prediction tools work for Granulomatous disease, chronic, X-linked
Observed separation of ClinVar pathogenic / likely pathogenic from benign / likely benign variants (AUROC × 100). This benchmark is not a clinical recommendation.
- CATVariant: 98 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- AlphaMissense: 97 out of 100
- ESM1b (LLR): 96 out of 100
- PolyPhen-2: 95 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- MutPred: 94 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- MetaLR: 92 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- SIFT: 89 out of 100
- MetaSVM: 87 out of 100 (learned from overlapping clinical labels, so this is optimistic)
Diseases related to Granulomatous disease, chronic, X-linked
- Chronic granulomatous disease, also linked to CYBB
- X-linked Mendelian susceptibility to mycobacterial diseases due to CYBB deficiency, also linked to CYBB
Frequently asked questions
Which genes have records linked to Granulomatous disease, chronic, X-linked?
This view contains 1 analyzed proteins: CYBB. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 39 pathogenic or likely pathogenic variants, 87 variants of uncertain significance and 12 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 2 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 165 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center